10 Things You Didn’t Know about The Oxford Vaccine Group

Vaccinations

The Oxford Vaccine Group is a research group that falls under the University of Oxford’s Department of Paediatrics. Like its name says, it specializes in vaccines as well as vaccine-related topics, meaning that it has become a subject of considerable interest in recent times because of the COVID-19 crisis.

1. Studies Vaccines For Both Children and Adults

Even though the Oxford Vaccine Group falls under the Department of Paediatrics, it is important to note that it is interested in vaccines for both children and adults. This presumably makes it much easier for the researchers to look into a wide range of vaccine-related issues without stepping beyond the boundaries of their mission.

2. Founded By Richard Moxon

Those who are curious should know that Richard Moxon founded the Oxford Vaccine Group in 1994. At the time, Moxon was looking into a couple of issues. One was the public health impact of Haemophilus influenzae, a bacteria that was suspected as a potential cause of influenza until the latter’s viral nature was established in 1933. The other was the effectiveness of the Haemophilus influenzae type B vaccine on children in the United Kingdom. Since that time, the Oxford Vaccine Group has continued to look into similar issues involving similar circumstances.

3. Multidisciplinary Group

Naturally, the Oxford Vaccine Group is a multidisciplinary group. Certainly, experts in vaccinology play a very important role in its operations. However, there is a wide range of other experts in other fields who contribute as well, with examples ranging from statisticians, immunologists, and epidemiologists to both a bioethicist and a sociologist.

4. Has Strict Guidelines On Conflicts of Interest

Of course, the Oxford Vaccine Group has strict guidelines when it comes to conflicts of interest. After all, their findings are useless unless people are willing to trust in them, meaning that they have very good reason to maintain their reputation for fair and unbiased conduct. One example of these guidelines can be seen in how the funders and sponsors of their studies are always revealed in the scientific publications related to those studies. Another example of these guidelines can be seen in how the members of the Oxford Vaccine Group are not permitted to accept gifts from vaccine manufacturers, are not permitted to serve on advisory boards for vaccine manufacturers, are not permitted to seek travel funding from vaccine manufacturers, and so on and so forth.

5. Has Studied Meningitis C Vaccine

One example of the Oxford Vaccine Group’s research would be its investigation of the Meningitis C vaccine, which focused on its effectiveness in the mid term as well as the long term. For those who are unfamiliar, Meningitis C prevents a disease that starts out with fatigue, fever, and headaches before proceeding to much more dangerous symptoms such as sepsis as well as inflammation of the membranes that protect the brain and the spinal cord. The study showed that the immunity provided by the Meningitis C vaccine wanes over time, thus prompting changes to the vaccination schedule.

6. Has Studied Meningitis B Vaccine

Speaking of which, the Oxford Vaccine Group studied a new Meningitis B vaccine in 2006, which resulted in its licensing in 2013. It is interesting to note that the researchers handled Phase II out of the four phases of clinical trials. In short, Phase II is when researchers look into whether a medical treatment has any efficacy or not while also looking out for side effects. About one in three medical treatments manage to make it past Phase II, thus enabling the researchers to move on to the more expensive and more time-consuming Phase III.

7. Has Studied Vaccines For Bird Flu, Swine Flu, and Ebola

Perhaps unsurprisingly, the Oxford Vaccine Group has studied vaccines for other high-profile diseases in the last couple of decades. For example, it has looked into vaccines for both bird flu and swine flu, which are called thus because they are caused by influenza viruses that tend to be found in those animals respectively. Likewise, the Oxford Vaccine Group has looked into a vaccine for ebola, which caused some serious worldwide concern in 2014. Unfortunately, while that particular outbreak of ebola has been contained, it has since shown up in the Democratic Republic of the Congo.

8. Has Launched the Vaccine Knowledge Project

The Oxford Vaccine Group has launched the Vaccine Knowledge Project, which is meant to be an authoritative source of information about vaccines and vaccination. This is important because the spread of misinformation has caused very noticeable drops in vaccination rates in considerable chunks of the English-speaking world, thus letting measles and other preventable diseases make a return. The Vaccine Knowledge Project is meant to convince interested individuals that getting vaccinated is a much safer choice than not getting vaccinated, which isn’t just beneficial for the person getting the shot but also society as a whole. After all, not everyone can actually get vaccinated due to various medical issues, meaning that they are reliant on other people getting vaccinated to protect them through herd immunity.

9. Working On a Vaccine For the Novel Coronavirus

Currently, the Oxford Vaccine Group is working on a vaccine for the novel coronavirus, which is something that it shares with a number of other parties in a number of other countries. Under normal circumstances, it takes years and years for a new vaccine to get approved. However, the urgency of the situation means that everyone is speeding things up, with the result that the relevant time-frame might be measured in months instead.

10. No Guarantee That an Effective Vaccine Can Be Made

Having said that, it is important to note that there is no guarantee that an effective vaccine will be made. After all, no vaccine for other forms of the coronavirus has ever been approved for use in the United States and the United Kingdom, which would be very bad because that means that society will just have to live with it for the foreseeable future. Besides that, even if either the Oxford Vaccine Group or some other party comes up with an effective vaccine, there are still enormous logistical challenges that will have to be solved to make it available in the numbers necessary for everything to return to the previous normal.

Add Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Business expenses
20 Things You Didn’t Know About Soldo
Arvind Purushotham
10 Things You Didn’t Know About Arvind Purushotham
Go1
20 Things You Didn’t Know About Go1
Andrew Barnes
10 Things You Didn’t Know About Andrew Barnes
Credit Card
10 Reasons We Like The Divvy Business Credit Card
Tesla
The Top Five Stock Picks Targeted at Climate Change
Credit Card
The 20 Best Travel Credit Cards of 2021
Wine
20 Things You Didn’t Know About Vinovest
Airline Miles
How You Can Now Redeem Miles for Flights to Space
Oklahoma State park
The 10 Best State Parks in Oklahoma
Cruise Ship
How to Book a Cruise Using Points and Miles
Bullet Train
China’s 373 MPH Bullet Train is World’s Fastest Land Vehicle
10 Things You Didn’t Know about The Bugatti Divo
Dodge Raider
Remembering The Short Lived Dodge Raider
Aston Martin Cygnet
The History and Evolution of the Aston Martin Cygnet
What is an Interference Engine and What is it Used For?
Patek Phillipe’s Green-Dial Nautilus
A Closer Look at the Patek Philippe’s Green-Dial Nautilus
A Closer Look at the Creux Automatiq Ghost V3 Mono
Seven Fridays
A Closer Look at the SevenFriday’s P1C/04 Caipi Watch
Doxa Sub 200 Whitepearl
A Closer Look at the The Doxa Sub 200 Whitepearl
Nancy Cartwright
How Nancy Cartwright Achieved a Net Worth of $80 Million
Heart Evangelista
How Heart Evangelista Achieved a Net Worth of $3 Million
How Cote De Pablo Achieved a Net Worth of $6 Million
How Upchurch Achieved a Net Worth of $4 Million